Observed arrival · 2026-11-05
GRAIL-HCC’s living treatment-evidence map
An open map of meta-analyses comparing treatments for hepatocellular carcinoma, organized by treatment hierarchy and comparison class.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- HCC clinicians and comparative-treatment researchers
- Worth noticing
- The map spans seven treatment-hierarchy tiers; its bubbles count meta-analyses, not patients or treatment effects.
Field notes
The map’s colors show the share of reviews based only on randomized trials, while bubble size reflects the number of meta-analyses. The page warns that volume and study design are not measures of quality, and says AMSTAR 2 methodological appraisal is in progress. It reports that resection has not been compared with systemic therapy in a dedicated meta-analysis.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
One card from the complete issue